Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.14M Buy
7,651
+1,369
+22% +$360K 0.02% 398
2026
Q1
$1.68M Buy
6,282
+184
+3% +$49.8K 0.02% 450
2025
Q4
$1.54M Buy
6,098
+669
+12% +$178K 0.02% 441
2025
Q3
$1.56M Sell
5,429
-117
-2% -$31.3K 0.02% 440
2025
Q2
$1.46M Buy
5,546
+2,529
+84% +$616K 0.02% 452
2025
Q1
$702K Sell
3,017
-2,082
-41% -$505K 0.01% 678
2024
Q4
$1.17M Buy
5,099
+2,596
+104% +$596K 0.02% 519
2024
Q3
$549K Buy
2,503
+377
+18% +$82.9K 0.01% 854
2024
Q2
$432K Buy
+2,126
New +$432K 0.01% 884

Other funds holding LH

Choreo LLC's LH Position: Q2 2026 in Review

Choreo LLC increased its Labcorp (LH) stake by 22% in Q2 2026, buying an estimated $360K and bringing the position to 7,651 shares worth $2.14M. The position accounts for 0.02% of the portfolio, ranked #398.

Choreo LLC first reported a position in LH in Q2 2024 and has held it in 9 quarters since. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Choreo LLC held 7,651 shares of Labcorp worth $2.14M as of Q2 2026.
  • Choreo LLC bought 1,369 Labcorp shares in Q2 2026, an estimated $360K.
  • Labcorp made up 0.02% of Choreo LLC's portfolio in Q2 2026, its #398 holding.
  • Choreo LLC first reported a position in Labcorp in Q2 2024 and has held it in 9 quarters since.
  • 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.